HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of growth factors in brain tumors: correlation with tumor grade, recurrence and survival.

AbstractOBJECTIVE:
The aim of this study is to evaluate the correlation between the expression of some growth factors (GFs) and the tumor grade, recurrence and survival of brain glial and ependymal tumors.
MATERIAL AND METHODS:
The expression of vascular endothelial growth factor (VEGF), epidermal growth factor receptor (EGFR), tenascine, transforming growth factor (TGFbeta), isomeres, platelet-derived growth factor (PDGF) and p53 was studied in 40 primary brain tumors, both low-grade and high-grade, including astrocytomas, oligodendrogliomas, glioblastomas and ependymomas. The same GFs were also studied in 46 specimens of recurrent tumors from the same patients. The positivity and intensity of the immunohistochemical expression were correlated with the tumor grade, the interval and type of recurrence, and the survival.
RESULTS:
The expression of all GFs, excepting TGFbeta1, TGFbetaRI and tenascine, was found to be correlated with the tumor grade in all tumors of both astroglial and oligodendroglial origin, whereas ependymomas showed significant differences only for EGFR. Low-grade (Grade II) tumors recurring as anaplastic (Grade III) forms showed GF expression rather similar to initially high-grade gliomas and significantly higher than that of low-grade (Grade II) tumors in both initial surgery and recurrence. Besides, low-grade (Grade II) tumors recurring as low-grade showed significantly longer median recurrence time (5.4 vs. 3.5 years) and better median survival (8.3 vs. 5.4 years) than those recurring as anaplastic forms (WHO III).
CONCLUSION:
The immunohistochemical study of expression of VEGF, EGFR, TGFbeta2, TGFbeta3, PDGF and p53 in all low-grade (Grade II) brain gliomas at the first operation may help to differentiate cases with slower evolution and longer survival from those with higher potential of anaplastic transformation.
AuthorsF Maiuri, M Del Basso De Caro, A Siciliano, C Peca, P Vergara, G Mariniello, G Pettinato
JournalClinical neuropathology (Clin Neuropathol) 2010 Mar-Apr Vol. 29 Issue 2 Pg. 109-14 ISSN: 0722-5091 [Print] Germany
PMID20175962 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Intercellular Signaling Peptides and Proteins
Topics
  • Adolescent
  • Adult
  • Aged
  • Biomarkers, Tumor (analysis)
  • Brain Neoplasms (metabolism, mortality, pathology)
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Immunohistochemistry
  • Immunophenotyping
  • Intercellular Signaling Peptides and Proteins (biosynthesis)
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local (metabolism)
  • Prognosis
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: